Return to List

Study Summary
No. 2009-0369:.......Other Studies......Aung Naing......Investigational Cancer Therapeutics
.
Study Summary Title
Study Summary
Number:		2009-0369
Study Title:Complementary and Alternative Medicine Usage Among Patients seen in the Phase I Clinical Trials Program.
.
Physician New Patient Referral
Name:Aung NaingPatients Call:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:Investigational Cancer TherapeuticsReferring MD
Call:		800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:713-563-1930
Contact us about clinical trials
.
General Information
Disease Group:Other StudiesSupported By:N/A
Phase of Study:N/AReturn
Visit:		N/A
Treatment
Agents:		QuestionnaireHome Care:N/A
Treatment Loc:Only at MDACC
Estimated
Length of Stay
in Houston:		N/A
Description/
Intervention:		Unavailable
.
Study Objectives / Outcomes
Primary Objective
· The primary objective is to estimate the prevalence of use of complementary and alternative medicine (CAM) in patients with advanced malignancies who are seen in the Phase I clinic at MDACC.

Secondary Objective
· Examine the association between prevalence of CAM use and demographic and socioeconomic characteristics (age, gender, race, income, and education level), participation in a phase I clinical trial, disease characteristics (diagnosis), patients' perceptions about their prognosis, physicians' information and permission for patients' CAM use, decision-making, and types of CAM used by patients.
.
Study Status Information
Study Activation / Registration Date:07/28/2009
IRB Review and Approval Date:07/28/2009
Study Type:Behavioral
Recruitment Status:Open
Projected Accrual:N/A
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.
Inclusion Criteria:1) Patients with a clinical diagnosis of advanced malignancy who are seen in the Phase I clinic.
Exclusion Criteria:1) Presence of any clinically relevant condition that, in the opinion of the investigator/ coordinator, would interfere with completing the study including, but not limited to, visual problems, cognitive impairment or acute mental illness.
.
Links
Registration Number: NCT00949390
Study Information on Clinical Trials Registry (clinicaltrials.gov)
Other Links:
.
Results

Return to Clinical Trials at M.D. Anderson Cancer Center